|
IQVIA™ Real-World Insights Bibliography
| Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study |
| Author(s):
John K. Marshall MD, MSc, FRCPC 1, Louis Bessette MD, MSc, FRCPC 2, Neil H. Shear MD, FRCPC 3, 4, Gerald Lebovic PhD 5, 6, Jennifer Glass PhD 7, Brad Millson MBS 7, Tania Gaetano BComm, MIS 8, Sandra Gazel MBA, MSc 8, Martin G. Latour PhD 8, Marie-Claude Laliberté PhD 8, J. Carter Thorne MD, FRCP 5, 6 |
| Affiliations(s): 1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada
2 Department of Medicine, Laval University, Quebec City, Quebec, Canada
3 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
4 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
5 Applied Health Research Centre, St. Michael's Hospital, Toronto, Ontario, Canada
6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
7 QuintilesIMS, Health Access and Outcomes, Kirkland, Quebec, Canada
8 AbbVie Corporation, St. Laurent, Quebec, Canada |
| Publication(s): |
| Document Type(s): |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Miscellaneous,
2018 |
|
L:
A: |
English
Longitudinal study, Retrospective cohort analysis, |
|
 |
| |
| |
| pCPA CHANGES AND IMPACT TO MARKET ACCESS IN CANADA:
RESULTS FROM AN OBSERVATIONAL CROSS-SECTIONAL STUDY |
| Author(s): Minhas, Jagdeep, M.Biotech 1; Iqbal-Khan, Sarah, MBA 2; Laforty, Callahan, MSc 2; Millson, Brad, MBS 1 |
| Affiliations(s): 1
1 Health Access and Outcomes, IQVIA, 535 Legget Drive, Kanata, ON, K2K 3B8
2 Health Access and Outcomes, IQVIA, 6755 Century Avenue, Mississauga, ON, L5N 6A4 |
Publication(s): 2018 CADTH Symposium, April 15-17, 2018, Halifax, NS, Canada
|
| Document Type(s): Poster, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Miscellaneous,
2018 |
|
L:
A: |
English
Observational study, |
|
|
| |
| |
| Translating clinical guidelines into electronic health records criteria to identify patients eligible for treatment
|
| Author(s): Zylbersztejn A, Hardelid P
|
| Affiliations(s): IQVIA/UCL
|
| Publication(s): |
| Document Type(s): Oral communication, |
| Countries: UK, |
C:
Y: |
Miscellaneous,
2018 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
| Prevalence of Primary Biliary Cholangitis in Canada: First National Study |
| Author(s): Yoshida EM1, Thiele S2, Fischer A2, Mason A3, Shah H4, Peltekian K5, Hux M2, Borrelli R2 |
| Affiliations(s): 1 Division of Gastroenterology, University of British Columbia 2 QuintilesIMS 3 University of Alberta 4 University of Toronto 5 Dalhousie University |
Publication(s): CANADIAN DIGESTIVE DISEASES 2017 CONFERENCE, MARCH 3-6, BANFF, Canada
|
| Document Type(s): Poster, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Miscellaneous,
2017 |
|
L:
A: |
English
Retrospective cohort analysis, |
|
|
| |
| |
| Linking individual-level data on diagnoses and dispensing for research on antibiotic use: Evaluation of a novel data source from English secondary care
|
| Author(s): Patrick Rockenschaub, David Ansell, Laura J Shallcross
|
| Affiliations(s): UCL/IQVIA
|
Publication(s):
|
| Document Type(s): |
| Countries: UK, |
C:
Y: |
Miscellaneous,
2017 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
| Short and long term costs associated with different cardiovascular events in Belgium. |
| Author(s): Caekelbergh K1, Chevalier P1, Lamotte M1, Kutikova L2, Schutyser E3, Annemans L4 |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 nv Amgen sa, Brussels, Belgium, 4 Ghent University - Brussels University, Ghent, Belgium |
Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
|
| Document Type(s): Abstract, |
| Countries: Belgium, |
C:
Y: |
Miscellaneous,
2016 |
|
L:
A: |
English
Cost of illness, |
|
|
| |
| |
| Hospitalization costs associated with Crohn's disease and ulcerative colitis in Belgium. |
| Author(s): Chevalier P, Lamotte M |
| Affiliations(s): QuintilesIMS, Zaventem, Belgium |
Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
|
| Document Type(s): Abstract, |
| Countries: Belgium, |
C:
Y: |
Miscellaneous,
2016 |
|
L:
A: |
English
Cost of illness, |
|
|
| |
| |
| The Burden of Gout in Ontario, Canada: A study of healthcare resource utilization in a Canadian public payer context |
| Author(s): Williams DM1, Cowan C1, Gendron A1, Goodfi eld J2, Cloutier M2, Fischer A2, Borrelli R2, Dziarmaga A1 |
| Affiliations(s): 1 AstraZeneca Canada, Mississauga, ON, Canada L4Y 1M4 2 IMS Brogan, A unit of IMS Health, Mississauga, ON, Canada L5N 6A4 |
| Publication(s): |
| Document Type(s): Poster, |
| Countries: |
| Click here for the abstract |
C:
Y: |
Miscellaneous,
2016 |
|
L:
A: |
English
Retrospective cohort analysis, |
|
|
| |
| |
| No Substitution: Not just for Physicians Anymore |
| Author(s): Gillman A, Fischer A |
| Affiliations(s): QuintilesIMS, Toronto, Canada |
Publication(s): 2016 Annual CAPT Conference
|
| Document Type(s): Poster, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Miscellaneous,
2016 |
|
L:
A: |
English
Review, |
|
|
| |
| |
| A quantitative evaluation of the growth in non-physician prescribing in Canada and the resultant impact to key provinces and therapeutic areas |
| Author(s): Shojaie S, Trickett R, Dobson-Belaire WN |
| Affiliations(s): QuintilesIMS, Montreal, Canada |
| Publication(s): |
| Document Type(s): Poster, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Miscellaneous,
2016 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
 2 of 22 
|
|
